BDX vs NDRA · P/E 34, rev $21.84B vs P/E 0.0, $2.6M cap
Becton Dickinson and Company (BDX) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
NDRA does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the BDX and NDRA stock pages for the full models.
Not investment advice.